• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall Beta2Microglobulin Urine Kit

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
 Class 2 Device Recall Beta2Microglobulin Urine Kitsee related information
Date Initiated by FirmMarch 09, 2018
Create DateApril 03, 2018
Recall Status1 Terminated 3 on June 22, 2020
Recall NumberZ-1301-2018
Recall Event ID 79499
510(K)NumberK122066 
Product Classification System, test, beta-2-microglobulin immunological - Product Code JZG
ProductBinding Site Optilite Beta-2-Microglobulin Urine Kit, Ref LK043.L.OPT.A, IVD. The firm name on the label is The Binding Site Group Ltd., Birmingham, U.K. The Optilite Beta-2-Microglobulin (2M) Urine kit is intended for the quantitative in-vitro measurement of beta-2-microglobulin in urine using the Binding Site Optilite analyser to aid in the diagnosis of active rheumatoid arthritis and kidney disease. This test should be used in conjunction with other laboratory and clinical findings.
Code Information Lot 407460, UDI 05051700017688
FEI Number 3002808340
Recalling Firm/
Manufacturer
The Binding Site Group, Ltd.
8 Calthorpe Road
Birmingham United Kingdom
For Additional Information Contact
800-633-4484
Manufacturer Reason
for Recall
The product is not meeting the antigen excess protection claim of up to 760mg/L, as stated in the Instructions for Use.
FDA Determined
Cause 2
Under Investigation by firm
ActionThe recalling firm notified their U.S. location by letter dated 3/6/2018 via email on 3/9/2018.
Quantity in Commerce20 kits distributed to the U.S.
DistributionUS Distribution was made to CA. There was no foreign/military/government distribution.
Total Product Life CycleTPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
510(K) Database510(K)s with Product Code = JZG
-
-